Tristar Wellness
Tristar Wellness Solutions Inc. engages in the development, marketing, and sale of wound care products. The company offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical … Read more
Tristar Wellness (TWSI) - Net Assets
Latest net assets as of September 2015: $-14.51 Million USD
Based on the latest financial reports, Tristar Wellness (TWSI) has net assets worth $-14.51 Million USD as of September 2015.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.82 Million) and total liabilities ($17.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-14.51 Million |
| % of Total Assets | -513.95% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 219.44 |
Tristar Wellness - Net Assets Trend (2001–2014)
This chart illustrates how Tristar Wellness's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tristar Wellness (2001–2014)
The table below shows the annual net assets of Tristar Wellness from 2001 to 2014.
| Year | Net Assets | Change |
|---|---|---|
| 2014-12-31 | $-11.07 Million | -204.99% |
| 2013-12-31 | $-3.63 Million | -317.72% |
| 2012-12-31 | $-869.00K | +62.26% |
| 2011-12-31 | $-2.30 Million | -14.99% |
| 2010-12-31 | $-2.00 Million | -245.24% |
| 2009-12-31 | $-580.00K | +71.43% |
| 2008-12-31 | $-2.03 Million | +10.68% |
| 2007-12-31 | $-2.27 Million | -615.71% |
| 2006-12-31 | $440.75K | +168.29% |
| 2005-12-31 | $-645.43K | -176.83% |
| 2004-12-31 | $840.05K | +140.30% |
| 2003-12-31 | $-2.08 Million | -1595.29% |
| 2002-12-31 | $-122.96K | +79.12% |
| 2001-12-31 | $-588.84K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tristar Wellness's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2997715500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2014)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.00K | % |
| Other Comprehensive Income | $182.00K | % |
| Other Components | $20.06 Million | % |
| Total Equity | $-11.07 Million | 100.00% |
Tristar Wellness Competitors by Market Cap
The table below lists competitors of Tristar Wellness ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WATER RES GRP
BE:WXV
|
$1.02K |
|
Alveen
PA:MLALV
|
$1.02K |
|
Zahraa Maadi Investment & Development
EGX:ZMID
|
$1.03K |
|
RAVEN RUSSIA (R4M.SG)
STU:R4M
|
$1.03K |
|
ACTIVEX
BE:A4T
|
$1.02K |
|
PhaseRx Inc
PINK:PZRXQ
|
$1.02K |
|
Arete Industries Inc
PINK:ARET
|
$1.02K |
|
Imagin Medical Inc
PINK:IMEXF
|
$1.02K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tristar Wellness's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2013 to 2014, total equity changed from -3,630,000 to -11,071,000, a change of -7,441,000.
- Net loss of 8,874,000 reduced equity.
- Other comprehensive income increased equity by 201,000.
- Other factors increased equity by 1,232,000.
Equity Change Factors (2013 to 2014)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.87 Million | -80.16% |
| Other Comprehensive Income | $201.00K | +1.82% |
| Other Changes | $1.23 Million | +11.13% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Tristar Wellness's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $-33.94 | $0.11 | x |
| 2006-12-31 | $40.81 | $0.11 | x |
| 2007-12-31 | $-143.41 | $0.11 | x |
| 2008-12-31 | $-105.51 | $0.11 | x |
| 2010-12-31 | $-50.10 | $0.11 | x |
| 2011-12-31 | $0.00 | $0.11 | x |
| 2012-12-31 | $-21.18 | $0.11 | x |
| 2013-12-31 | $-0.12 | $0.11 | x |
| 2014-12-31 | $-0.48 | $0.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tristar Wellness utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -159.92%
- • Asset Turnover: 1.81x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-26.65%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 0.00% | 0.00% | 0.00x | 0.00x | $-636.35K |
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-338.70K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.95 Million |
| 2004 | -485.61% | -77894.84% | 0.00x | 1.75x | $-4.16 Million |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.07 Million |
| 2006 | 139.19% | 9.26% | 1.93x | 7.79x | $569.40K |
| 2007 | 0.00% | -465.80% | 0.56x | 0.00x | $-4.78 Million |
| 2008 | 0.00% | -235.34% | 0.25x | 0.00x | $-1.66 Million |
| 2010 | 0.00% | -258.88% | 0.91x | 0.00x | $-2.18 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-58.12K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.16 Million |
| 2013 | 0.00% | -334.43% | 0.68x | 0.00x | $-12.27 Million |
| 2014 | 0.00% | -159.92% | 1.81x | 0.00x | $-7.77 Million |
Industry Comparison
This section compares Tristar Wellness's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tristar Wellness (TWSI) | $-14.51 Million | 0.00% | N/A | $1.02K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |